Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Gout and the Risk of Incident Erectile Dysfunction: A Body Mass Index-matched Population-based Study.

Schlesinger N, Lu N, Choi HK.

J Rheumatol. 2018 Jul 15. pii: jrheum.170444. doi: 10.3899/jrheum.170444. [Epub ahead of print]

PMID:
30008453
2.

Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout.

Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, Pinheiro GDRC, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2018 May 25. doi: 10.1002/acr.23607. [Epub ahead of print]

PMID:
29799677
3.

Chronic tophaceous gout as the first manifestation of gout in two cases and a review of the literature.

Bieber A, Schlesinger N, Fawaz A, Mader R.

Semin Arthritis Rheum. 2018 Jun;47(6):843-848. doi: 10.1016/j.semarthrit.2017.11.006. Epub 2017 Nov 27.

PMID:
29275830
4.

The Hepato-Hypothalamic-Pituitary-Adrenal-Renal Axis: Mathematical Modeling of Cortisol's Production, Metabolism, and Seasonal Variation.

Pierre K, Schlesinger N, Androulakis IP.

J Biol Rhythms. 2017 Oct;32(5):469-484. doi: 10.1177/0748730417729929. Epub 2017 Sep 25.

PMID:
28946788
5.

Daily Moderate Exercise Is Beneficial and Social Stress Is Detrimental to Disease Pathology in Murine Lupus Nephritis.

Aqel SI, Hampton JM, Bruss M, Jones KT, Valiente GR, Wu LC, Young MC, Willis WL, Ardoin S, Agarwal S, Bolon B, Powell N, Sheridan J, Schlesinger N, Jarjour WN, Young NA.

Front Physiol. 2017 Apr 26;8:236. doi: 10.3389/fphys.2017.00236. eCollection 2017.

6.

Sex differences in gout characteristics: tailoring care for women and men.

Harrold LR, Etzel CJ, Gibofsky A, Kremer JM, Pillinger MH, Saag KG, Schlesinger N, Terkeltaub R, Cox V, Greenberg JD.

BMC Musculoskelet Disord. 2017 Mar 14;18(1):108. doi: 10.1186/s12891-017-1465-9.

7.

The impact of multisensory instruction on learning letter names and sounds, word reading, and spelling.

Schlesinger NW, Gray S.

Ann Dyslexia. 2017 Oct;67(3):219-258. doi: 10.1007/s11881-017-0140-z. Epub 2017 Mar 2.

PMID:
28255950
8.

The safety of treatment options available for gout.

Schlesinger N.

Expert Opin Drug Saf. 2017 Apr;16(4):429-436. doi: 10.1080/14740338.2017.1284199. Epub 2017 Jan 30. Review.

PMID:
28095258
9.

Crystal arthritis: New recommendations highlight the need for more research.

Schlesinger N.

Nat Rev Rheumatol. 2016 Nov;12(11):628-630. doi: 10.1038/nrrheum.2016.150. Epub 2016 Sep 9. No abstract available.

PMID:
27627869
10.

X-ray diffraction analysis of spontaneously draining calcinosis in scleroderma patients.

Hsu VM, Emge T, Schlesinger N.

Scand J Rheumatol. 2017 Mar;46(2):118-121. doi: 10.1080/03009742.2016.1219766. Epub 2016 Sep 28.

PMID:
27682520
11.

Dr. Schlesinger replies.

Schlesinger N.

J Rheumatol. 2016 Aug;43(8):1617. doi: 10.3899/jrheum.160394. No abstract available.

PMID:
27481992
12.

The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity.

Pierre K, Schlesinger N, Androulakis IP.

Physiol Genomics. 2016 Oct 1;48(10):719-738. doi: 10.1152/physiolgenomics.00006.2016. Epub 2016 Jun 24.

13.

Beyond Joints: a Review of Ocular Abnormalities in Gout and Hyperuricemia.

Sharon Y, Schlesinger N.

Curr Rheumatol Rep. 2016 Jun;18(6):37. doi: 10.1007/s11926-016-0586-8. Review.

PMID:
27138165
14.

New and Pipeline Drugs for Gout.

Keenan RT, Schlesinger N.

Curr Rheumatol Rep. 2016 Jun;18(6):32. doi: 10.1007/s11926-016-0579-7. Review.

PMID:
27097819
15.

Gout Prophylaxis Evaluated According to the 2012 American College of Rheumatology Guidelines: Analysis from the CORRONA Gout Registry.

Schlesinger N, Etzel CJ, Greenberg J, Kremer J, Harrold LR.

J Rheumatol. 2016 May;43(5):924-30. doi: 10.3899/jrheum.150345. Epub 2016 Mar 15.

PMID:
26980578
16.

The Potential of Circadian Realignment in Rheumatoid Arthritis.

Rao RT, Pierre KK, Schlesinger N, Androulakis IP.

Crit Rev Biomed Eng. 2016;44(3):177-191. doi: 10.1615/CritRevBiomedEng.2016018812. Review.

17.

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.

de Lautour H, Taylor WJ, Adebajo A, Alten R, Burgos-Vargas R, Chapman P, Cimmino MA, da Rocha Castelar Pinheiro G, Day R, Harrold LR, Helliwell P, Janssen M, Kerr G, Kavanaugh A, Khanna D, Khanna PP, Lin C, Louthrenoo W, McCarthy G, Vazquez-Mellado J, Mikuls TR, Neogi T, Ogdie A, Perez-Ruiz F, Schlesinger N, Ralph Schumacher H, Scirè CA, Singh JA, Sivera F, Slot O, Stamp LK, Tausche AK, Terkeltaub R, Uhlig T, van de Laar M, White D, Yamanaka H, Zeng X, Dalbeth N.

Arthritis Care Res (Hoboken). 2016 May;68(5):667-72. doi: 10.1002/acr.22741.

18.

Did Michelangelo Have Gout?

Pinals RS, Schlesinger N.

J Clin Rheumatol. 2015 Oct;21(7):364-7. doi: 10.1097/RHU.0000000000000301.

PMID:
26398464
19.

Adherence to the 2012 American College of Rheumatology (ACR) Guidelines for Management of Gout: A Survey of Brazilian Rheumatologists.

Vargas-Santos AB, Castelar-Pinheiro Gda R, Coutinho ES, Schumacher HR Jr, Singh JA, Schlesinger N.

PLoS One. 2015 Aug 14;10(8):e0135805. doi: 10.1371/journal.pone.0135805. eCollection 2015.

20.

Use of dual-energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosis.

Hsu V, Bramwit M, Schlesinger N.

Clin Rheumatol. 2015 Sep;34(9):1557-61. doi: 10.1007/s10067-015-2998-7. Epub 2015 Jul 3.

21.

Diagnosis and Treatment of Acute Gout at a University Hospital Emergency Department.

Schlesinger N, Radvanski DC, Young TC, McCoy JV, Eisenstein R, Moore DF.

Open Rheumatol J. 2015 Jun 12;9:21-6. doi: 10.2174/18743129014090100021. eCollection 2015.

22.

Erectile Dysfunction Is Common among Patients with Gout.

Schlesinger N, Radvanski DC, Cheng JQ, Kostis JB.

J Rheumatol. 2015 Oct;42(10):1893-7. doi: 10.3899/jrheum.141031. Epub 2015 May 1.

PMID:
25934822
23.

Percutaneous yttrium aluminum garnet-laser lithotripsy of intrahepatic stones and casts after liver transplantation.

Schlesinger NH, Svenningsen P, Frevert S, Wettergren A, Hillingsø J.

Liver Transpl. 2015 Jun;21(6):831-7. doi: 10.1002/lt.24120. Epub 2015 May 6.

24.

Dual-energy computed tomography for the evaluation of calcinosis in systemic sclerosis.

Hsu V, Bramwit M, Schlesinger N.

J Rheumatol. 2015 Feb;42(2):345-6. doi: 10.3899/jrheum.140773. No abstract available.

PMID:
25641967
25.

Non-steroidal anti-inflammatory drugs for acute gout.

van Durme CM, Wechalekar MD, Buchbinder R, Schlesinger N, van der Heijde D, Landewé RB.

Cochrane Database Syst Rev. 2014 Sep 16;(9):CD010120. doi: 10.1002/14651858.CD010120.pub2. Review.

PMID:
25225849
26.

Colchicine for acute gout.

van Echteld I, Wechalekar MD, Schlesinger N, Buchbinder R, Aletaha D.

Cochrane Database Syst Rev. 2014 Aug 15;(8):CD006190. doi: 10.1002/14651858.CD006190.pub2. Review.

PMID:
25123076
27.

Treatment of acute gout.

Schlesinger N.

Rheum Dis Clin North Am. 2014 May;40(2):329-41. doi: 10.1016/j.rdc.2014.01.008. Epub 2014 Feb 19. Review.

PMID:
24703350
28.

[Dealing with surgical complications after bariatric gastric bypass surgery].

Schlesinger NH, Naver L.

Ugeskr Laeger. 2013 Nov 25;175(48):2945-8. Review. Danish.

PMID:
24629437
29.

Is the longitudinal margin of carcinoma-bearing colon resections a neglected parameter?

Rørvig S, Schlesinger N, Mårtensson NL, Engel S, Engel U, Holck S.

Clin Colorectal Cancer. 2014 Mar;13(1):68-72. doi: 10.1016/j.clcc.2013.11.007. Epub 2013 Nov 20.

PMID:
24503112
30.

Anti-interleukin-1 therapy in the management of gout.

Schlesinger N.

Curr Rheumatol Rep. 2014 Feb;16(2):398. doi: 10.1007/s11926-013-0398-z. Review.

PMID:
24407823
31.

OMERACT endorsement of measures of outcome for studies of acute gout.

Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, Alten R, March L, Strand V, Wells G, Khanna D, McQueen F, Schlesinger N, Boonen A, Boers M, Saag KG, Schumacher HR, Edwards NL.

J Rheumatol. 2014 Mar;41(3):569-73. doi: 10.3899/jrheum.131246. Epub 2013 Dec 15.

32.

[Need for new thinking in surgical education].

Schlesinger NH, Hillingsø JG.

Ugeskr Laeger. 2013 May 6;175(19):1326. Danish. No abstract available.

PMID:
23663367
33.

Intra-articular glucocorticoids for acute gout.

Wechalekar MD, Vinik O, Schlesinger N, Buchbinder R.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009920. doi: 10.1002/14651858.CD009920.pub2. Review.

PMID:
23633379
34.

Previously reported prior studies of cherry juice concentrate for gout flare prophylaxis: comment on the article by Zhang et al.

Schlesinger N, Schlesinger M.

Arthritis Rheum. 2013 Apr;65(4):1135-6. doi: 10.1002/art.37864. No abstract available.

35.

Canakinumab in gout.

Schlesinger N.

Expert Opin Biol Ther. 2012 Sep;12(9):1265-75. doi: 10.1517/14712598.2012.705825. Epub 2012 Jul 12. Review.

PMID:
22784099
36.

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.

Schlesinger N, Alten RE, Bardin T, Schumacher HR, Bloch M, Gimona A, Krammer G, Murphy V, Richard D, So AK.

Ann Rheum Dis. 2012 Nov;71(11):1839-48. doi: 10.1136/annrheumdis-2011-200908. Epub 2012 May 14.

PMID:
22586173
37.

Treatment of chronic gouty arthritis: it is not just about urate-lowering therapy.

Schlesinger N.

Semin Arthritis Rheum. 2012 Oct;42(2):155-65. doi: 10.1016/j.semarthrit.2012.03.010. Epub 2012 Apr 26. Review.

PMID:
22542277
38.

Significance of acquired diverticular disease of the vermiform appendix: a marker of regional neoplasms?

Kallenbach K, Hjorth SV, Engel U, Schlesinger NH, Holck S.

J Clin Pathol. 2012 Jul;65(7):638-42. doi: 10.1136/jclinpath-2011-200647. Epub 2012 Mar 29.

PMID:
22461655
39.

Tophaceous pustule-like rash in a patient with gout.

Chehab MR, Goyal J, Schlesinger N.

J Rheumatol. 2012 Jan;39(1):194-5. doi: 10.3899/jrheum.110376. No abstract available.

PMID:
22210683
40.

Difficult-to-treat gouty arthritis: a disease warranting better management.

Schlesinger N.

Drugs. 2011 Jul 30;71(11):1413-39. doi: 10.2165/11592290-000000000-00000. Review.

PMID:
21812506
41.
42.

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.

Schlesinger N, Mysler E, Lin HY, De Meulemeester M, Rovensky J, Arulmani U, Balfour A, Krammer G, Sallstig P, So A.

Ann Rheum Dis. 2011 Jul;70(7):1264-71. doi: 10.1136/ard.2010.144063. Epub 2011 May 3.

43.

Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study.

Schlesinger N, De Meulemeester M, Pikhlak A, Yücel AE, Richard D, Murphy V, Arulmani U, Sallstig P, So A.

Arthritis Res Ther. 2011 Mar 25;13(2):R53. doi: 10.1186/ar3297.

44.

Pegloticase.

Schlesinger N, Yasothan U, Kirkpatrick P.

Nat Rev Drug Discov. 2011 Jan;10(1):17-8. doi: 10.1038/nrd3349. No abstract available. Erratum in: Nat Rev Drug Discov. 2011 Feb;10(2):156.

PMID:
21193861
45.

The pathogenesis of bone erosions in gouty arthritis.

Schlesinger N, Thiele RG.

Ann Rheum Dis. 2010 Nov;69(11):1907-12. doi: 10.1136/ard.2010.128454. Epub 2010 Aug 12.

PMID:
20705636
46.

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study.

So A, De Meulemeester M, Pikhlak A, Yücel AE, Richard D, Murphy V, Arulmani U, Sallstig P, Schlesinger N.

Arthritis Rheum. 2010 Oct;62(10):3064-76. doi: 10.1002/art.27600.

47.

New agents for the treatment of gout and hyperuricemia: febuxostat, puricase, and beyond.

Schlesinger N.

Curr Rheumatol Rep. 2010 Apr;12(2):130-4. doi: 10.1007/s11926-010-0093-2. Review.

PMID:
20425022
48.

Diagnosing and treating gout: a review to aid primary care physicians.

Schlesinger N.

Postgrad Med. 2010 Mar;122(2):157-61. doi: 10.3810/pgm.2010.03.2133. Review.

PMID:
20203467
49.

Does acute synovitis (pseudogout) occur in patients with chronic pyrophosphate arthropathy (pseudo-osteoarthritis)?

Schlesinger N, Hassett AL, Neustadter L, Schumacher HR Jr.

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):940-4.

PMID:
20149309
50.

Progress in measurement instruments for acute and chronic gout studies.

Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, Schlesinger N, Evans R, Edwards NL, Sivera F, Diaz-Torne C, MacDonald PA, McQueen FM, Schumacher HR.

J Rheumatol. 2009 Oct;36(10):2346-55. doi: 10.3899/jrheum.090371.

PMID:
19820224

Supplemental Content

Loading ...
Support Center